# ENANTA PHARMACEUTICALS INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/enanta-pharmaceuticals-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 27 | | Claims under review | 1 | | Evidence records | 6 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-07T06:08:00.422417+00:00 | | Last reviewed | 2026-10-07T06:08:00.422417+00:00 | ## Identity - Legal name: ENANTA PHARMACEUTICALS INC - Display name: ENANTA PHARMACEUTICALS INC ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-07T23:55:28.524012+00:00 | | Completeness | 0.409 | | Record Quality | 0.827 | | Directors | 10 | | Committees | 3 | | Governance events | 7 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Harry R. Trout, III: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-26. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:6 - Jay R. Luly, Ph.D.: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-26. Committees: Calendar Year Target Variable Compensation Committee (member). claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:8 - Kristine Peterson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2017-01-01. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:9 - Tara L. Kieffer: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2026-01-26. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:12 - Terry C. Vance: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2011-01-01. Committees: By the Audit Committee (member). claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:13 - Bruce L.A. Carter: Non-Executive Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:5 - Jay R. Luly: President, Director and Chief Executive Officer. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: Director and Chief Executive Officer (member). claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:7 - Lesley Russell: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:10 - Mark G. Foletta: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:11 - Yujiro S. Hata: Director. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:14 ## Committees - By the Audit Committee (audit). Chair: NOT_PUBLISHED. Members: Terry C. Vance (member, current); Terry C. Vance (member, unknown). committee_id=alpha:committee:enanta-pharmaceuticals-inc:by-the-audit-committee - Calendar Year Target Variable Compensation Committee (compensation). Chair: NOT_PUBLISHED. Members: Jay R. Luly, Ph.D. (member, current); Jay R. Luly, Ph.D. (member, unknown). committee_id=alpha:committee:enanta-pharmaceuticals-inc:calendar-year-target-variable-compensation-committee - Director and Chief Executive Officer (executive). Chair: NOT_PUBLISHED. Members: Jay R. Luly (member, unknown). committee_id=alpha:committee:enanta-pharmaceuticals-inc:director-and-chief-executive-officer ## Executive leadership - Jay R. Luly, Ph.D.: President and Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:18 - Kathleen S. Capps: Executive Director of Accounting, Controller [CAO]. Status: current. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:19 - Brendan Luu: Chief Business Officer. Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:15 - Harry R. Trout: Vice President, Finance (Principal Financial Officer). Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:16 - Jay R. Luly: President and Chief Executive Officer [CEO]. Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:17 - Matthew P. Kowalsky: Chief Legal Officer and Corporate Secretary [GC]. Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:20 - Scott T. Rottinghaus: Chief Medical Officer. Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:21 - Tara L. Kieffer: Chief Product Strategy Officer. Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:22 - Yat Sun Or: Chief Scientific Officer. Status: unknown. claim_id=alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:23 ## Governance events - DIRECTOR_APPOINTED: Harry R. Trout, III seat on ENANTA PHARMACEUTICALS INC, effective 2026-01-26. Effective: 2026-01-26. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:director_appointed:l5cq0c - DIRECTOR_APPOINTED: Jay R. Luly, Ph.D. seat on ENANTA PHARMACEUTICALS INC, effective 2026-01-26. Effective: 2026-01-26. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:director_appointed:7ulvso - DIRECTOR_APPOINTED: Tara L. Kieffer seat on ENANTA PHARMACEUTICALS INC, effective 2026-01-26. Effective: 2026-01-26. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:director_appointed:16onzko - CEO_CHANGED: Jay R. Luly, Ph.D. executive of ENANTA PHARMACEUTICALS INC, effective 2025-11-19. Effective: 2025-11-19. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:ceo_changed:4kgl95 - EXECUTIVE_APPOINTED: Kathleen S. Capps executive of ENANTA PHARMACEUTICALS INC, effective 2025-11-19. Effective: 2025-11-19. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:executive_appointed:1e5r2ht - DIRECTOR_APPOINTED: Kristine Peterson seat on ENANTA PHARMACEUTICALS INC, effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:director_appointed:shfcnt - DIRECTOR_APPOINTED: Terry C. Vance seat on ENANTA PHARMACEUTICALS INC, effective 2011-01-01. Effective: 2011-01-01. Detected: 2026-10-07T06:08:00.422417+00:00. event_id=alpha:event:director_appointed:zm42ss ## Scoped resources - `alpha://company/enanta-pharmaceuticals-inc` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record - `alpha://company/enanta-pharmaceuticals-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=identity - `alpha://company/enanta-pharmaceuticals-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=corporate-structure - `alpha://company/enanta-pharmaceuticals-inc/board` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=board - `alpha://company/enanta-pharmaceuticals-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=committees - `alpha://company/enanta-pharmaceuticals-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=leadership - `alpha://company/enanta-pharmaceuticals-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=ownership - `alpha://company/enanta-pharmaceuticals-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=financials - `alpha://company/enanta-pharmaceuticals-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=capital-structure - `alpha://company/enanta-pharmaceuticals-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=compensation - `alpha://company/enanta-pharmaceuticals-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=governance - `alpha://company/enanta-pharmaceuticals-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=shareholder-governance - `alpha://company/enanta-pharmaceuticals-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=audit - `alpha://company/enanta-pharmaceuticals-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=legal - `alpha://company/enanta-pharmaceuticals-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=risk - `alpha://company/enanta-pharmaceuticals-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=cyber - `alpha://company/enanta-pharmaceuticals-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=ai-governance - `alpha://company/enanta-pharmaceuticals-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=agents - `alpha://company/enanta-pharmaceuticals-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=ecosystem - `alpha://company/enanta-pharmaceuticals-inc/events` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=events - `alpha://company/enanta-pharmaceuticals-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=relationships - `alpha://company/enanta-pharmaceuticals-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=assessments - `alpha://company/enanta-pharmaceuticals-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:committee_appointment:25: `{"kind":"committee_appointment","original_name":"By the Audit Committee","category":"audit","role":"member","person":{"alpha_id":"alpha:person:terry-c-vance-enta","name":"Terry C. Vance"},"source_id":"governance_people_committees"}` - Claim alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:committee_appointment:27: `{"kind":"committee_appointment","original_name":"Calendar Year Target Variable Compensation Committee","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:jay-r-luly-ph-d","name":"Jay R. Luly, Ph.D."},"source_id":"governance_people_committees"}` ## Leadership - Bruce L.A. Carter: Non-Executive Chairman of the Board. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Harry R. Trout, III: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:6. Valid from: 2026-01-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb8e3aabe8d818d27b151ce97e481fc702129ae3fa0632f6630eccbd432c2449. - Jay R. Luly: President, Director and Chief Executive Officer. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Jay R. Luly, Ph.D.: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:8. Valid from: 2026-01-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb8e3aabe8d818d27b151ce97e481fc702129ae3fa0632f6630eccbd432c2449. - Kristine Peterson: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:9. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb8e3aabe8d818d27b151ce97e481fc702129ae3fa0632f6630eccbd432c2449. - Lesley Russell: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:10. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Mark G. Foletta: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Tara L. Kieffer: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:12. Valid from: 2026-01-26. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb8e3aabe8d818d27b151ce97e481fc702129ae3fa0632f6630eccbd432c2449. - Terry C. Vance: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:13. Valid from: 2011-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:cb8e3aabe8d818d27b151ce97e481fc702129ae3fa0632f6630eccbd432c2449. - Yujiro S. Hata: Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Brendan Luu: Chief Business Officer. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Harry R. Trout: Vice President, Finance (Principal Financial Officer). Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Jay R. Luly: President and Chief Executive Officer. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Jay R. Luly, Ph.D.: President and Chief Executive Officer and Director. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:18. Valid from: 2025-11-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:dd7b767a00ae491b3005ab7ad3a24439ea0ed5a44f2e3a89144b3241670eaa77. - Kathleen S. Capps: Executive Director of Accounting, Controller. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:19. Valid from: 2025-11-19. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:354df21d1506325a22bc296480a75feaef2139c1ed944164381b16d503c6fc30. - Matthew P. Kowalsky: Chief Legal Officer and Corporate Secretary. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Scott T. Rottinghaus: Chief Medical Officer. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Tara L. Kieffer: Chief Product Strategy Officer. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. - Yat Sun Or: Chief Scientific Officer. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:leadership_role:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - By the Audit Committee: Chair not stated; Members Terry C. Vance. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:committee_record:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a947840cc904965cae9e899367a71e81e4e02a492820c801cd904554bdedcfe1. - Calendar Year Target Variable Compensation Committee: Chair not stated; Members Jay R. Luly, Ph.D.. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:committee_record:26. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a947840cc904965cae9e899367a71e81e4e02a492820c801cd904554bdedcfe1. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - ENANTA PHARMACEUTICALS INC. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b44317e2ce094acf5ed4fde8d17ea5472a0b3c541e27b904597c7d427ce601b9. ## Entity Status - Public listing published. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b44317e2ce094acf5ed4fde8d17ea5472a0b3c541e27b904597c7d427ce601b9. ## Published Fact - US. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b44317e2ce094acf5ed4fde8d17ea5472a0b3c541e27b904597c7d427ce601b9. ## Committee Appointment - Terry C. Vance: member, By the Audit Committee. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:committee_appointment:25. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a947840cc904965cae9e899367a71e81e4e02a492820c801cd904554bdedcfe1. - Jay R. Luly, Ph.D.: member, Calendar Year Target Variable Compensation Committee. Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:committee_appointment:27. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:a947840cc904965cae9e899367a71e81e4e02a492820c801cd904554bdedcfe1. ## Security Listing - ENTA (NASDAQ). Claim: alpha:claim:company:bd8dd75c-6b4a-4b81-b9de-b6732699a641:security_listing:28. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:b44317e2ce094acf5ed4fde8d17ea5472a0b3c541e27b904597c7d427ce601b9. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:b44317e2ce094acf5ed4fde8d17ea5472a0b3c541e27b904597c7d427ce601b9: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc). - alpha:projection-evidence:document:03858fc04d1a2ecf3dc28e43f3554953635c3dd5a85a82a4619708e4fcde2aea: [SEC DEF 14A 0001193125-26-022558](https://www.sec.gov/Archives/edgar/data/1177648/000119312526022558/enta-20260126.htm). - alpha:projection-evidence:document:cb8e3aabe8d818d27b151ce97e481fc702129ae3fa0632f6630eccbd432c2449: [DEF 14A enta-20260126.htm](https://www.sec.gov/Archives/edgar/data/1177648/000119312526022558/enta-20260126.htm). - alpha:projection-evidence:document:dd7b767a00ae491b3005ab7ad3a24439ea0ed5a44f2e3a89144b3241670eaa77: [ENTA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1177648/000119312525288121/enta-20250930.htm). - alpha:projection-evidence:document:354df21d1506325a22bc296480a75feaef2139c1ed944164381b16d503c6fc30: [ENTA 10-K executive officers](https://www.sec.gov/Archives/edgar/data/1177648/000119312525288121/enta-20250930.htm). - alpha:projection-evidence:a947840cc904965cae9e899367a71e81e4e02a492820c801cd904554bdedcfe1: [By the Audit Committee](https://www.sec.gov/Archives/edgar/data/1177648/000119312526022558/enta-20260126.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/enanta-pharmaceuticals-inc) - [Public Markdown](https://registry.alpha.ac/companies/enanta-pharmaceuticals-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/enanta-pharmaceuticals-inc?format=jsonld) - MCP resource: `alpha://companies/enanta-pharmaceuticals-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-07T23:55:28.516653+00:00; recorded 2026-10-07T23:55:28.516653+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.